MedecoNovo Research selects Nextphase ctSeries to provide electronic data collection for clinical trials
We are delighted to partner with MedecoNovo Research in providing electronic data collection and management solutions to its clients across North America, said Michael Currie, CEO of Nextphase. MedecoNovo Research is one of the first Canadian-based clinical research organizations (CROs) to leverage Nextphase's Web-based ctSeries, which significantly reduces cycle times and helps speed clinical development.''
With the utilization of Nextphase's ctSeries as a clinical research technology platform we will be able to provide our clients with a proven data collection methodology that will enhance our ability to acquire high quality data at a very reasonable cost, said Denis Bilodeau, General Manager of MedecoNovo Research.
According to Nextphase, its Nextphase ctSeries is designed to improve access to information, facilitate communication among all participants and accelerate the overall conduct of clinical trials to enable pharmaceutical, biotechnology, and medical device companies to launch new products more quickly, for enhanced revenues and increased patent life.